Covid-19 vaccines aren’t making any money for Johnson & Johnson ...Middle East

Quartz - Economy
Covid-19 vaccines aren’t making any money for Johnson & Johnson
For many Americans, Johnson & Johnson (J&J) these days is most closely associated with the pharmaceutical company’s Covid-19 vaccine, which has been recently suspended in the US as authorities investigate its risk of causing a rare blood clot syndrome.But for J&J, the vaccine is nowhere near its main product, at least not in terms of revenue. Out of over $22 billion in sales, Covid-19 vaccines accounted for $100 million—or just above 2%, the company announced today.This pales in comparison with the makers of the other vaccines licensed in the US, Moderna and Pfizer. The two companies have projected yearly sales from the vaccine to be $18 billion and $15 billion respectively, without counting

Hence then, the article about covid 19 vaccines aren t making any money for johnson johnson was published today ( ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Covid-19 vaccines aren’t making any money for Johnson & Johnson )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in Economy


Latest News